International Clinical Trial: The efficacy and safety of microporous polysaccharide hemostasis powder combined with standard endoscopy versus standard endoscopy alone in the treatment of high-risk peptic ulcer bleeding: A prospective, multicenter, single-blind, randomized controlled study

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118511) titled 'The efficacy and safety of microporous polysaccharide hemostasis powder combined with standard endoscopy versus standard endoscopy alone in the treatment of high-risk peptic ulcer bleeding: A prospective, multicenter, single-blind, randomized controlled study' on Feb. 6.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Nanchang University

Condition: Peptic ulcer bleeding (Forrest Ia-IIa) requiring emergency endoscopic hemostasis

Intervention: Hemostatic Powder plus Standard Endoscopic Therapy Group:Microporous polysaccharide hemostatic powder combine...